Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA™) -: Review of the literature and six years of clinical experience

被引：20
|
作者：
Braun, M
Mathers, M
Bondarenko, B
Engelmann, U
机构：
[1] Univ Cologne, Dept Urol, DE-50924 Cologne, Germany
[2] Dept Urol, Remscheid, Germany
来源：
UROLOGIA INTERNATIONALIS | 2004年 / 72卷 / 01期
关键词：
transurethral needle ablation of the prostate; BPH; long-term results;
D O I：
10.1159/000075270
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Following FDA clearance and the establishment of Medicare coverage, transurethral needle ablation ( TUNA) has become an established and widely-adopted treatment method for BPH in the USA. Germany is lagging behind at present, though a change can also be recognized there. The lack of long-term data has often been criticized. This review presents an overview of clinical outcomes of TUNA, long-term results and patient selection criteria. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码：32 / 39
页数：8
相关论文
共 50 条
12345